Hare Joshua
Chief Scientific Officer at LGVN
- Sold, on record
- $729k
- Dollars the filings state
- Form 4 sales
- 5
- Latest May 16, 2025
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- LGVNLongeveron Inc.Chief Scientific Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale LGVNPlan not statedApr 19, 2022 2022
Sold 20,000 shares at $10.00 ($200k)
Hare Joshua, Chief Scientific Officer
Sold 0.3% of holdings ($79.3M position)7.9M shares leftFirst sale on recordFiling
- 2 Form 4 sale LGVNPlan not statedOct 12, 2022 +176 days
Sold 100,000 shares at $3.61 ($361k)
Hare Joshua, Chief Scientific Officer
Sold 1.3% of holdings ($28.6M position)7.8M shares leftFiling
- 3 Form 4 sale LGVNPlan not statedDec 2, 2022 +51 days
Sold 20,000 shares at $3.74 ($75k)
Hare Joshua, Chief Scientific Officer
Sold 0.3% of holdings ($29.3M position)7.8M shares leftFiling
- 4 Form 4 sale LGVNPlan not statedJan 27, 2023 +56 days
Sold 20,000 shares at $4.28 ($86k)
Hare Joshua, Chief Scientific Officer
Sold 0.3% of holdings ($33.4M position)7.8M shares left1x usual sizeFiling
- 5 Form 144 notice LGVNNoticeMay 15, 2025 +839 days
Filed to sell 5,250 shares ($7k)
Hare Joshua, Officer, Director
No 10b5-1 planFirst sale on recordFiling
- 6 Form 4 sale LGVNNo planMay 16, 2025 +1 day
Sold 5,250 shares at $1.40 ($7k)
Hare Joshua, Chief Scientific Officer
No 10b5-1 planSold 0.7% of holdings ($1M position)721,796 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (6)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 16, 2025 | LGVN | Chief Scientific Officer | Form 4 sale | 5,250 | $7k | 0.7% | No plan | SEC |
| May 15, 2025 | May 15, 2025 | LGVN | Officer, Director | Form 144 notice | 5,250 | $7k | Notice | SEC | |
| Jan 27, 2023 | Jan 30, 2023 | LGVN | Chief Scientific Officer | Form 4 sale | 20,000 | $86k | 0.3% | Plan not stated | SEC |
| Dec 2, 2022 | Dec 5, 2022 | LGVN | Chief Scientific Officer | Form 4 sale | 20,000 | $75k | 0.3% | Plan not stated | SEC |
| Oct 12, 2022 | Oct 18, 2022 | LGVN | Chief Scientific Officer | Form 4 sale | 100,000 | $361k | 1.3% | Plan not stated | SEC |
| Apr 19, 2022 | Apr 20, 2022 | LGVN | Chief Scientific Officer | Form 4 sale | 20,000 | $200k | 0.3% | Plan not stated | SEC |